Patents by Inventor Jens Kastrup

Jens Kastrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STEM CELL THERAPY BASED ON ADIPOSE-DERIVED STEM CELLS
    Publication number: 20180325957
    Abstract: The present invention relates to adipose-derived stem cells (ASCs) and compositions, as well as methods for preparing and using such ASCs and compositions for therapy.
    Type: Application
    Filed: October 21, 2016
    Publication date: November 15, 2018
    Applicant: Rigshospitalet
    Inventors: Jens Kastrup, Annette Ekblond, Mandana Haack-Sørensen
  • CLASSIFICATION OF INDIVIDUALS SUFFERING FROM CARDIOVASCULAR DISEASES ACCORDING TO SURVIVAL PROGNOSES AS FOUND BY MEASURING THE LEVELS OF BIOMARKER YKL-40
    Publication number: 20110070601
    Abstract: The present invention relates to the method of measuring the YKL-40 level and using this measurement as a prognosis for survival of an individual suffering from heart disease caused by atherosclerosis. The method may be used for classification of individuals in order to optimize treatment or monitoring the individuals during the course of or prior to or after treatment. The individual may suffer from any type of cardiovascular disease or disorder. The method also detects and determines whether diagnostically or prognostically significant levels of YKL-40 molecules are present in a biological sample. Furthermore the level of YKL-40 may be used to predict disease relapse.
    Type: Application
    Filed: January 22, 2009
    Publication date: March 24, 2011
    Applicant: Rigshospitalet
    Inventor: Jens Kastrup